×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

 

Amgen Korea Celebrates New Office Opening

Amgen Korea held on June 2, 2016, an event to celebrate its new office opening and the launch of its first two medicines in Korea. Amgen’s Korean affiliate officially opened in Seoul in November 2015. Speakers at the June 2 opening event included Desmond Padhi, Amgen vice president, Medical Sciences; Penny Wan, vice president and general manager of Amgen’s Japan Asia Pacific Region; and Sang Noh, general manager of Amgen’s Korean affiliate.

“Amgen looks forward to being an active member of the local biotechnology community and helping to advance the growth of this industry in Korea,” said Sang Noh. “Amgen Korea is committed to continuing to provide innovative medicines to Korean patients, in accordance with our global mission to serve seriously ill patients,” Noh added.


Korea Team